Novo GLP-1 drug shows less lean mass loss than rivals, study says

As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.

Train-to-Test scaling explained: How to optimize your end-to-end AI compute budget for inference

AI reasoning does not necessarily require spending huge amounts on frontier models. Instead, smaller models can yield ...

Study looks into which weight-loss drug makes you lose the most muscle

A new study suggests that Eli Lilly’s GLP-1 drug tirzepatide, marketed as Zepbound and Mounjaro, leads to greater overall ...

Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds

By Nancy Lapid April 16 (Reuters) - Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo ...

Solid Power: I View The Stock As A Call Option With A $2.50 Strike

Solid Power stock is a "Hold" as a speculative pre-commercial energy-tech bet. Click to learn more about SLDP's valuation and ...